Here, in this study, we developed cell and transgenic mouse models for NAFLD to investigate the potential pathophysiological roles and regulatory mechanisms of 11β-HSD1, in association with GR, gp78, and Insig1/2. The gene discussed is AMFR; the disease is metabolic dysfunction-associated steatotic liver disease.